r The reduced oxygen tension of high altitude compromises performance in lowlanders. In this environment, Sherpa display superior performance, but little is known on this issue.
Introduction
The reduction in partial pressure of inspired oxygen (P I O 2 ) with ascent to high altitude leads to multiple, interconnected adjustments within the locomotor system that compromise the ability of humans to perform physical activity (Martin et al. 2010 ). When exposed acutely to hypoxia, individuals who reside close to sea level (lowlanders) present greater fatigue and impaired physical performance, compared to normoxia (Katayama et al. 2010; Jubeau et al. 2017; . With continued exposure to high altitude (i.e. acclimatisation), the human body undergoes systemic changes (West, 2012) , which result in partial or complete recovery of both fatigability and performance to normoxic levels (Kayser et al. 1994; Amann et al. 2013; Goodall et al. 2014; . Adaptation to altitude-related hypoxia is a subject of great debate (Dempsey & Morgan, 2015) , and with reference to peripheral fatigability (i.e. at or distal to the neuromuscular junction), the mechanisms are poorly understood (Perrey & Rupp, 2009) .
Although lowlanders show marked adaptations with short-or medium-term exposure to hypoxia (0-14 days and 14-42 days, as defined by Horscroft & Murray 2014) , Sherpa are the descendants of people who have inhabited the Tibetan Plateau for >21,000 years (Zhao et al. 2009 ). Consequently, Sherpa possess unique genotypic and phenotypic characteristics (Ge et al. 2015; Simonson, 2015; Horscroft et al. 2017; Murray et al. 2018 ) that lead to remarkable physical performance at high altitude (Gilbert-Kawaii et al. 2014) . At the level of the muscle, Sherpa present numerous physiological differences compared to acclimatised lowlanders. These include reduced muscle fibre cross-sectional area and mitochondrial density (Kayser et al. 1991) , decreased mitochondrial oxidative capacity but increased coupling efficiency (Horscroft & Murray, 2014; Horscroft et al. 2017) , and greater protection against oxidative stress (Horscroft et al. 2017) . The latter two physiological characteristics would lead to smaller metabolic changes in the muscle and enhanced resistance to cellular mechanisms of skeletal muscle fatigue, especially in a hypoxic environment. However, to date there are no data to compare muscle performance and peripheral fatigability at altitude in Sherpa and lowlanders.
In a study designed to assess supraspinal fatigue and neural excitability during a voluntary sustained isometric elbow flexor task, we found recently that the fatigue-induced decrease in peripheral excitability (maximal compound muscle action potential) observed in lowlanders was absent in Sherpa (Ruggiero & McNeil, 2018) . We attributed the finding to a superior ability of the muscles of Sherpa to keep pace with the contraction-induced efflux of potassium ions. Although the measure reflected a peripheral-level difference between groups with fatiguing activity, the central nervous system unavoidably influences muscle fibres during volitional tasks. To best assess muscle-level responses to repetitive activity (i.e. peripheral fatigue), the fatiguing task itself should have no influence from the central nervous system. In humans, the most effective way to minimise a role of the central nervous system is to apply external stimulation to a peripheral nerve or muscle belly to induce muscle contraction (Maffiuletti, 2010) .
Hence, the purpose of the present experiment was to use electrically-evoked contractions to study peripheral fatigue in acclimatised age-matched lowlanders and Sherpa at an altitude of 5050 m. Contractile properties related to knee extensor force as well as measures of muscle oxygenation and blood flow were monitored during and after application of intermittent muscle belly stimulation to the quadriceps of the dominant leg. In light of the muscle phenotypic characteristics typically exhibited by Sherpa, we hypothesised that this group, compared to lowlanders, would exhibit lower impairment of muscle contractile capabilities and faster recovery from fatigue at high altitude. took place from October to November 2016. All testing procedures were approved by the Clinical Research Ethical Review Board of the University of British Columbia (Application ID: H16-01028), and conformed to the standards set by the Declaration of Helsinki, except for registration in a database.
Participants
Twelve lowlanders (mean ± SD; height: 1.77 ± 0.06 m; body mass: 77 ± 9 kg) and 10 Sherpa (height: 1.67 ± 0.08 m; body mass: 66 ± 15 kg) took part in the study. The groups were age-matched (lowlanders, age: 32 ± 10 years; Sherpa, age: 31 ± 11 years). All Sherpa were born, and habitually residing, in the Khumbu valley (>3440 m). The time spent at elevation in their lifetime ranged between 12 and 59 years. All participants were members of the research expedition, and provided informed written consent. Two lowlanders and nine Sherpa also took part in our recent investigation of central fatigue in the two groups (Ruggiero & McNeil, 2018) ; however, only the baseline pulse oximeter data of arterial saturation (S p O 2 ) and heart rate (HR) overlap between studies. Haematological variables reported in this study were obtained from the UBC-Nepal Expedition database.
Study design
All experimental procedures were conducted at an altitude of 5050 m above sea level at the Ev-K2-CNR Pyramid Laboratory (Nepal, barometric pressure = 413 ± 4 mmHg, P I O 2 = 76 ± 1 mmHg), within 3-9 days of arrival. Participants (including Sherpa) met in Kathmandu, where they sojourned 3-7 days, then flew to Lukla (2860 m) and trekked over 9 days to the Ev-K2-CNR Pyramid Laboratory, with two rest days in both Namche Bazaar (3440 m) and Pheriche (4240 m). Notably, this ascent profile was identical for both lowlanders and Sherpa. No participants used medications to prevent or treat acute mountain sickness (e.g. acetazolamide).
Experimental set-up
Participants were seated in a custom-built isometric dynamometer, with their dominant lower limb secured to a linear strain gauge with a strap just above the lateral malleolus, and a 90°angle of flexion at the knee joint. To minimise movement during contractions, a seatbelt was fastened tightly over the hips. The force produced during voluntary and electrically-evoked isometric knee extensions was measured by the strain gauge (SBO-300; Transducer Techniques, Temecula, CA, USA), amplified (×100) (Neurolog System NL109 module; Digitimer, Welwyn Garden City, UK), sampled at 1000 Hz using a 16-bit A/D converter (CED 1401-3; Cambridge Electronic Design, Cambridge, UK), and recorded using Spike2 software (version 7.10; Cambridge Electronic Design). The force was continuously displayed on a computer monitor to provide feedback to the participant during the experiment.
Haematological variables
On the second day of sojourn at 5050 m, arterial blood samples from the radial artery were drawn into pre-heparinised syringes and analysed immediately using an arterial blood-gas analysis system (ABL-90, Radiometer, Copenhagen, Denmark) to obtain haemoglobin (Hb), haematocrit (Hct), and partial pressure of arterial O 2 and CO 2 (P a O 2 and P a CO 2 , respectively). For technical reasons, Hb, Hct, P a O 2 and P a CO 2 data could not be obtained for two lowlanders and one Sherpa.
Arterial saturation
S p O 2 and HR were sampled using a pulse oximeter (MD300K1, Beijing Choice Electronic Technology, Beijing, China) placed on the middle finger of the left hand. During pilot testing conducted before the expedition (in both normoxic and normobaric hypoxic conditions), it was observed that there was no change in S p O 2 or HR across the experiment. Hence, only baseline measures were recorded for this study.
Near-infrared spectroscopy
A tissue oximeter (OxiplexTS, ISS, Champaign, IL, USA) was used to record muscle near-infrared spectroscopy (mNIRS) signals. An elastic strap held the mNIRS probe over the rectus femoris muscle, midway between the anterior superior iliac spine and the superior border of the patella. The OxiplexTS rigid probe has four pairs of near infrared light sources (four emitting at 690 nm and four emitting at 830 nm), located at different distances (2.0, 2.5, 3.0 and 3.5 cm) from the detector, providing the time course of the absolute concentrations (expressed in micromolar) of oxygenated haemoglobin (O 2 Hb), deoxygenated haemoglobin (HHb), and total haemoglobin (tHb = O 2 Hb + HHb). Changes in tHb can be interpreted as representing blood volume changes in the field of view of the probe (Millet et al. 2012) . The tissue oxygenation index (expressed as a percentage; TOI = O 2 Hb/tHb) was also calculated, and represents the dynamic balance between O 2 supply and O 2 consumption in tissue capillaries, arterioles and venules (Ferrari et al. 2004) . The mNIRS signals were sampled at 2 Hz using the OxiplexTS proprietary software. Recordings were initiated 1 min before baseline testing and continued until the end of the protocol.
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Blood flow measurement Superficial femoral artery blood flow was measured using a high-resolution ultrasound machine (Terason 3200, Teratech, Burlington, MA, USA). A 10 MHz linear array probe was used to image the superficial femoral artery in the sagittal plane. The angle of insonation for the acquisition of velocity was 60°. Screen capture of the ultrasound was saved as an audio-video interleave file (Camtasia Studio, TechSmith Corp., Okemos, MI, USA) for future analysis.
Muscle belly stimulation
Electrically-evoked contractions were elicited by means of two stimulating electrodes applied transversely over the muscle bellies of the quadriceps muscle of the dominant thigh, at one-third of the distance between the anterior superior iliac spine and the superior border of the patella (cathode), and 5 cm above the superior border of the patella (anode). The electrodes consisted of aluminium foil wrapped in a thin conductive gel-soaked cloth and were 7.5 cm high × ß12-16 cm wide, depending on the size of the thigh (Allman & Rice, 2004) . Square-wave electrical stimuli (200 μs pulse width; 100-400 V) were delivered by a computer-triggered stimulator (DS7AH, Digitimer). The stimulator intensity was set at a current to evoke 30% of the maximal voluntary contraction (MVC) force with a train of 12 pulses at 15 Hz (lowlanders: 20-70 mA; Sherpa: 11-45 mA). An elastic bandage wrapped around the thigh prevented movement of the electrodes or mNIRS probe.
Experimental procedures
Participants performed three brief (ß3 s) MVCs with strong verbal encouragement and visual feedback, to establish peak knee extension force. Each MVC was separated by at least 90 s of rest. Additional contractions were performed if maximal force increased by ࣙ5% with successive MVCs. Peak force was used to set a target on the computer monitor at 30% MVC force. The stimulator intensity was raised incrementally (5 mA steps) until the tetanus evoked by a train of 12 pulses at 15 Hz achieved the target force. After a few minutes of rest (used to obtain the optimal image of the superficial femoral artery), baseline superficial femoral artery diameter and blood velocity were recorded for 1 min before the fatiguing protocol started. The fatiguing protocol included three bouts of 75 trains of stimuli. Each train consisted of 12 pulses at 15 Hz, with 1.6 s separating the first pulse of successive trains. Each bout was separated by 15 s of rest. Recovery measures were performed at minutes 1, 2 and 3 after the end of the fatiguing protocol (R1, R2 and R3, respectively). At each time point, a train of 12 pulses at 15 Hz was delivered. Superficial femoral artery blood flow was recorded continuously during and after the protocol. However, due to movement of the artery caused by the evoked contractions and stimulation artifacts, blood flow measurements during the fatiguing protocol could be collected only in the 15 s separating each bout of contractions.
Data analysis and statistics
All mNIRS data were analysed off-line using custom MATLAB scripts (The MathWorks, Natick, MA, USA). O 2 Hb, HHb, tHb and TOI were averaged over 15 s time windows at nine points: just before the start and in the middle of the first, second and third bout of stimuli, and just before the delivery of the train at R1, R2 and R3. To represent the oxygen saturation kinetics at the beginning and at the end of the fatiguing protocol, the half-times of desaturation (during the first bout) and resaturation (after the third bout) were calculated, using a 2 s moving average window of TOI. Due to technical problems, we had to discard mNIRS data from one lowlander and one Sherpa.
Off-line analysis of force data was conducted with Signal software (v. 5.08; Cambridge Electronic Design). Data were first digitally filtered (50 Hz notch filter). For each tetanus, peak force, peak rate of force development and relaxation (pRFD and pRFR, respectively), and half-relaxation time (HRT) were calculated. pRFD and pRFR are calculated over a 6 ms interval (3 ms on either side of the steepest instantaneous slope). The contractile impulse of each tetanus was calculated as the area under the whole force-time curve (CI) or just the first 200 ms (CI 200 ). For measurements during the fatiguing protocol, the aforementioned variables were averaged within the first, middle and last five tetani of each bout. During the recovery period, the variables were obtained from the individual tetani evoked at R1, R2 and R3. The variables calculated as the average across the first five tetani of the first bout were considered as baseline measures.
At the beginning of the first bout, a transient potentiation of peak force in Sherpa and pRFD in both Sherpa and lowlanders was noted. For each participant, the tetanus number with the greatest peak force (lowlanders: 1 ± 0; Sherpa: 9 ± 8) and pRFD (lowlanders: 11 ± 3; Sherpa: 12 ± 4) was separately determined. Thereafter, potentiated peak force and pRFD were calculated as the average value of the interval including the tetanus reporting the maximum value and the respective two tetani on either side. The potentiation was then expressed as a percentage of the average peak force and pRFD of the first five tetani of the first bout. If the greatest peak force or pRFD occurred for the first or second tetanus, no potentiation was considered.
For determination of superficial femoral artery mean blood flow, audio-video interleave files collected during the experimental sessions were analysed using edge-detection software (FMD/BloodFlow Software Version 5.1, Reed C, Perth, Australia) (Woodman et al. 2001) . A region of interest was placed around the highest quality portion of the B-mode longitudinal image of the artery and a second region of interest surrounded the Doppler strip to record blood velocity. The software automatically and continuously tracked the walls of the vessel and peak envelope velocity trace within the regions of interest at a frequency of 30 Hz (Woodman et al. 2001) . Mean superficial femoral artery blood flow (ml min −1 ; calculated as peak envelope blood velocity [cm s
2 ) (Evans 1985) during the protocol was determined as the average across 1 min before the start of the fatiguing protocol (baseline), the 15 s of rest between each bout, and each 1 min window during recovery.
Using haematological variables and S p O 2 at rest, arterial O 2 content at baseline (C a O 2 , ml dL −1 ) was estimated using the equation (1.36
Of note, [Hb] and P a O 2 were obtained on the second day of sojourn at 5050 m, whereas S p O 2 was obtained at the beginning of the measurement session from pulse oximetry. To provide further insight into the role of oxygen delivery we have estimated delivery of oxygen (eDO 2 , ml min −1 ) as C a O 2 × superficial femoral artery mean blood flow.
Statistical analysis was conducted using SPSS Statistics version 23 (IBM Corp., Armonk, NY, USA). Normality of data was examined using skewness, kurtosis and the Shapiro-Wilk test. An independent samples Student's t test, or the Mann-Whitney U test when conditions of normality were not met, was used to compare between lowlanders and Sherpa baseline absolute values of S p O 2 , HR, Hb, Hct, P a O 2 , P a CO 2 , C a O 2 , TOI, superficial femoral artery mean blood flow, eDO 2 , MVC force and variables resulting from the electrically-induced contractions at baseline. The same tests were also used to compare the half-time of desaturation and resaturation, and the potentiation of peak force and pRFD at the start of the fatiguing protocol between groups.
Data collected during the fatiguing protocol and recovery were expressed as a percentage of baseline. Separately for both fatigue and recovery, variables were compared using two-way repeated measures ANOVA, with group as a between-subjects factor and time as a within-subjects factor. If only a main effect for time was found, data were pooled for the two groups and a paired-samples t test in conjunction with a Dunnett's table was used to determine which time points were different from baseline. If the two-way repeated measures ANOVA reported a significant main effect for group or time × group interaction, one-way repeated measures ANOVAs were run separately for each group to assess the effect of time. If significant, paired-samples t-tests and a Dunnett's table were used to determine which time points were different from baseline. For those two-way repeated measures ANOVAs which had a main effect of group, data were compared between lowlanders and Sherpa at each time point using the Tukey-Kramer test. All data are reported as mean ± SD in the text, and as mean ± SEM in the figures. The significance level was P < 0.05.
Results

Baseline measures
Baseline cardiovascular measures as well as MVC force for lowlanders and Sherpa are reported in Table 1 . No differences between groups were reported for S p O 2 (P = 0.19), HR (P = 0.07), Hb (P = 0.55), Hct (P = 0.92), P a O 2 (P = 0.11) and C a O 2 (P = 0.41); however, P a CO 2 was lower in lowlanders than Sherpa (3 mmHg; t(17) = −2.9, P < 0.05). Muscle TOI was greater in lowlanders than Sherpa (6 %; t(18) = 2.8, P < 0.05), while superficial femoral artery mean blood flow and eDO 2 were not different between groups (P = 0.15 and 0.13, respectively). The MVC force was greater in lowlanders than Sherpa (14 kg; t(20) = 2.9, P < 0.05). Baseline contractile parameters obtained from the electrically-induced contractions are reported in Table 2 . For the first five contractions of the first bout, as intended, the peak force was targeted at 30% of the MVC force, and not different between groups (P = 0.27). As a consequence, the absolute value of the peak force was lower in Sherpa than in lowlanders (3 kg; t(20) = 2.4, P < 0.05). For the same contractions, pRFD, pRFR, CI and CI 200 were lower, while HRT was longer, in Sherpa than in lowlanders (t(20) > 1.9, P < 0.05). 
Fatigue and recovery measures
Force responses. The potentiation of peak force during the initial part of the first bout was higher in Sherpa than in lowlanders (5.2 ± 5.9 % vs. 0 %; t(20) = 3.1, P < 0.05), with no differences between groups in the potentiation of pRFD (29.4 ± 22.8 % vs. 18.4 ± 14.8 %; P = 0.19). For peak force of the electrically-induced tetani (Fig. 1A) , there was a main effect of time (F 3.3,65.0 = 189.5, P < 0.05) and group (F 1,20 = 4.5, P < 0.05) during the fatiguing protocol, while only a main effect of time was found during recovery (F 1.2,24.1 = 32.7, P < 0.05). While peak force was significantly decreased at all time points in lowlanders during the fatiguing protocol (P < 0.05), in Sherpa, a decrease was evident only from the end of the first bout (P < 0.05). In addition, the decline from baseline was 8.5% more for lowlanders than Sherpa at the end of the first bout (P < 0.05). During recovery, with no between-group differences, post hoc testing on pooled data revealed that peak force remained lower than baseline at every time point (P < 0.05). Absolute pRFD and pRFR are depicted in Fig. 1B and C, respectively. Across the fatiguing protocol, each two-way repeated measures ANOVA reported only a main effect of time (pRFD: F 8,160 = 95.3, P < 0.05; pRFR: F 2.9,57.9 = 105.9, P < 0.05), and both pRFD and pRFR were slower at all time points (P < 0.05). During recovery, for pRFD there was a main effect of time (F 1.7,34.5 = 22.6, P < 0.05), group (F 1,20 = 7.0, P < 0.05), and a time × group interaction (F 1.7,34.5 = 5.3, P < 0.05). At all time points, pRFD was slower than control in lowlanders (P < 0.05) but equivalent to control in Sherpa; consequently, throughout recovery, pRFD was faster in Sherpa than in lowlanders (P < 0.05). For pRFR, only a main effect of time was found (F 1.4,26.9 = 62.1, P < 0.05); post hoc testing on pooled data revealed values slower than baseline throughout recovery (P < 0.05).
A slowing of the HRT occurred in both groups during the fatiguing protocol and failed to recover within 3 min (Fig. 1D) . The two-way repeated measures ANOVA yielded a main effect of time during the fatiguing protocol (F 2.5,47.6 = 79.2, P < 0.05), and post hoc testing on pooled data revealed significantly slower HRT at all time points (P < 0.05). During recovery, main effects for time (F 2.1,41.9 = 44.1, P < 0.05) and group (F 1,20 = 5.5, P < 0.05) as well as an interaction (F 2.1,41.9 = 3.7, P < 0.05) were found. The relaxation remained slowed in both groups at all recovery time points (P < 0.05), with HRT values being higher in lowlanders than in Sherpa (P < 0.05).
The CI and CI 200 are depicted in Fig. 2 . During the fatiguing protocol, for both measures, only a main effect of time was reported (CI: F 3.5,70.0 = 159.4, P < 0.05; CI 200 : F 2.6,51.8 = 134.7, P < 0.05), and post hoc testing on pooled data indicated that both measures were decreased from baseline at all time points (P < 0.05). During recovery, for CI ( Fig. 2A ) there was only a main effect of time (F 1.3,25.7 = 56.6, P < 0.05), and pooled data were still lower than baseline at each time point (P < 0.05). Differently, for CI 200 (Fig. 2B ), there were main effects of time (F 1.4,28.8 = 31.8, P < 0.05) and group (F 1,20 = 5.6, P < 0.05), and a time × group interaction (F 1.4,28.8 = 4.5, P < 0.05). Specifically, CI 200 was still decreased throughout recovery in lowlanders (P < 0.05), but only on the third minute of recovery in Sherpa (P < 0.05). When compared between groups, the recovery in CI 200 was greater in Sherpa than in lowlanders (P < 0.05).
Muscle tissue oxygenation parameters. At the start of the first bout of the fatiguing protocol, no differences were found in the half-time of desaturation between groups (lowlanders: 11.2 ± 2.5 s; Sherpa: 11.4 ± 2.0 s; P = 0.84). Likewise, the half-times of resaturation after the end of the fatiguing protocol were not different between groups (lowlanders: 12.5 ± 2.8 s; Sherpa: 13.4 ± 3.5 s; P = 0.59).
Values of TOI, tHb, O 2 Hb and HHb, normalised to baseline, are represented in Fig. 3 . For all measures, for both the fatiguing protocol and recovery, the two-way repeated measures ANOVAs reported only main effects of time (F > 16.6, P < 0.05) so post hoc testing was conducted on pooled data. TOI (Fig. 3A) was significantly decreased at all time points of the fatiguing protocol except the start of the third bout (P < 0.05), and greater than baseline throughout recovery (P < 0.05). tHb (Fig. 3B ) was increased at all time points during both fatigue and recovery (P < 0.05). O 2 Hb (Fig. 3C) showed a decrease during the first bout (P < 0.05), whereas at the start of the second and third bout as well as during recovery it was increased compared to baseline (P < 0.05). HHb (Fig. 3D) showed a significant increase throughout the fatiguing protocol (P < 0.05), whereas it was decreased compared to baseline at any time point during recovery (P < 0.05).
Blood flow and estimated delivery of oxygen. Superficial femoral artery mean blood flow and eDO 2 , as both absolute values and normalised to baseline, are depicted in Fig. 4 . For all measures, the two-way repeated measures ANOVA resulted in main effects of time only (F > 59.1, P < 0.05). When data were pooled, all variables were significantly greater than baseline throughout the fatiguing and recovery periods (P < 0.05).
Discussion
The aim of the current investigation was to examine differences between lowlanders and Sherpa in muscle fatigue, with negligible influence of central factors related to muscle activation. Our research led to four principal findings: (1) the decline of peak force of the electrically-evoked tetani was more marked in lowlanders than in Sherpa at the beginning of the protocol; (2) after the fatiguing protocol, the rate of force development and contractile impulse recovered earlier in Sherpa than in lowlanders; (3) after the fatiguing protocol, half-relaxation time recovered to a greater extent in Sherpa . Open symbols represent data points significantly different from baseline. A, peak force was significantly decreased at all time points in lowlanders during the fatiguing protocol, while in Sherpa a decrease was evident only from the end of the first bout (P < 0.05). In addition, the decline from baseline was greater in lowlanders than Sherpa at the end of the first bout ( * P < 0.05). During recovery, post hoc testing on pooled data showed a decrease in peak force throughout (P < 0.05). B, peak rate of force development (pRFD) was significantly slower in both groups (post hoc testing on pooled data) during the fatiguing protocol (P < 0.05). After the fatiguing protocol, pRFD remained depressed in lowlanders (P < 0.05) but recovered by 1 min in Sherpa. As a result, pRFD was faster in Sherpa than in lowlanders throughout recovery ( * P < 0.05). C, peak rate of force relaxation (pRFR) was significantly slower in both groups (post hoc testing on pooled data) during both the fatiguing protocol and recovery (P < 0.05). D, half-relaxation time (HRT) was slowed in both groups (post hoc testing on pooled data) at all time points during the fatiguing protocol (P < 0.05). Throughout recovery, HRT remained increased in both groups (P < 0.05) and was slower in lowlanders than in Sherpa ( * P < 0.05). J Physiol 596.22 than in lowlanders; (4) all of these differences occurred despite equivalent alterations of muscle oxygenation and estimated delivery of oxygen in both groups. The higher preservation of muscle performance in Sherpa compared to lowlanders at high altitude occurs independently of bulk muscle oxygen delivery and so is likely due to muscle metabolic adaptations in Sherpa.
Figure 2. Contractile impulse of the 15 Hz tetani during the fatiguing protocol and recovery
Mean values (± SEM) in lowlanders (circles, continuous line) and Sherpa (inverted triangles, dashed line). All values are expressed as percentage of baseline (mean value of the first 5 tetani of the fatiguing protocol). Open symbols represent data points significantly lower than baseline. A, contractile impulse (CI), calculated as the area under the whole force-time curve of the tetani, was lower than baseline in both groups (post hoc testing on pooled data) during both the fatiguing protocol and recovery (P < 0.05). B, contractile impulse of the first 200 ms of the tetani (CI 200 ) was decreased from baseline in both groups (post hoc testing on pooled data) during the fatiguing protocol (P < 0.05). During recovery, CI 200 was still decreased in lowlanders at all time points (P < 0.05) but only at 3 min in Sherpa (P < 0.05). When compared between groups, the recovery of CI 200 was greater in Sherpa than in lowlanders ( * P < 0.05).
Baseline variables
Prior to the fatiguing protocol, measures of S p O 2 , HR, Hb, Hct, C a O 2 and superficial femoral artery mean blood flow were not different between lowlanders and Sherpa. This is in accordance with previous reports comparing lowlanders and Sherpa at an altitude, time at altitude and ascent profile similar to ours (Lewis et al. 2014; Stembridge et al. 2014; Gilbert-Kawai et al. 2017; Horscroft et al. 2017) . The higher P a CO 2 in the Sherpa is consistent with the notion of a blunted hypoxic ventilatory response in this population (Lahiri et al. 1969; Samaja et al. 1997) . Muscular TOI was lower in Sherpa than in lowlanders. This may be due to the combination of (not statistically significant) lower P a O 2 , C a O 2 and superficial femoral artery mean blood flow in Sherpa. Moreover, the calculation of TOI in absolute terms is affected by a number of factors in addition to the concentration of O 2 Hb and tHb, particularly skin pigmentation, with darker pigmented skin augmenting signal loss from the NIRS probe (Wassenaar & Van den Brand, 2005) .
Maximal force of the knee extensors was lower in Sherpa than in lowlanders. We presume much of the difference is due to the smaller body mass of the Sherpa (independent sample t test: t(20) = 2.1, P < 0.05); however, we did not assess voluntary activation so it is possible that a lower central drive in Sherpa (Ruggiero & McNeil, 2018) contributed to the lower MVC force. Importantly, if voluntary activation was modestly lower in Sherpa than in lowlanders, it would have had a minimal impact on the targeted absolute force (30% MVC) for the submaximal fatiguing protocol (Ruggiero & McNeil, 2018) . All of peak force, pRFD and pRFR of the 15 Hz tetani were significantly lower in Sherpa than in lowlanders. When normalised to peak force of the tetanus, pRFD and pRFR were not different between groups (data not shown), which suggests that the slower absolute rates relate to the lower absolute peak force of the electrically-induced tetani. The combination of lower absolute peak force and pRFD in Sherpa than in lowlanders was mirrored by CI and CI 200 , which showed smaller values in Sherpa. Interestingly, HRT was longer in Sherpa than in lowlanders. A slower HRT may be related either to fibre type distribution or to slower Ca 2+ handling. There is not definitive evidence of greater type I fibre distribution in Sherpa than in lowlanders nor any data related to Ca 2+ handling in Sherpa. Regarding type I fibre distribution, the only data come from second-generation Tibetans born at 1300 m (Kayser et al. 1996) , and those values were similar to lowland Nepalese (Kayser et al. 1996) and within the range of Caucasian lowlanders (Lexell et al. 1986) . With respect to Ca 2+ handling, after a 21-day expedition to 6194 m, lowlanders had reduced Ca 2+ uptake from the sarcoplasmic reticulum in vastus lateralis (Green et al. 2000) . It is unknown whether this adaptation would exist or be exacerbated in Sherpa due to their long-term altitude adaptations.
Fatigue and recovery measures
Muscle tissue oxygenation and blood flow. The mNIRS-related variables, superficial femoral artery mean blood flow and eDO 2 responded similarly in both groups during the fatiguing protocol and recovery. This indicates that delivery and kinetics of oxygen as well as the balance between oxygen delivery and utilization were not different between groups. During the bouts of contractions, TOI was lower than baseline, due to decreased O 2 Hb but increased tHb. The elevated tHb throughout the fatiguing protocol (driven by an increase of HHb) suggests increased blood volume beneath the mNIRS probe. Inter-bout measures of superficial femoral artery mean blood flow and eDO 2 mirrored tHb, indicating an increase in blood flow to increase delivery of oxygen to the muscle. With respect to the calculation of C a O 2 and in turn eDO 2 , it is possible that [Hb] and P a O 2 continued to increase in some participants between the second day at 5050 m (when those measurements were taken) and the testing day. This may have underestimated eDO 2 at rest and during the fatiguing protocol. Importantly, any underestimation is likely to be similar in lowlanders and Sherpa because a study with an ascent profile similar to ours reported that the increase in [Hb] with increasing altitude was not different between groups (e.g. Gilbert-Kawaii et al. 2017) . This makes our measure of eDO 2 comparable between Figure 3 . Muscle near-infrared spectroscopy parameters across the fatiguing protocol and recovery Mean values (±SEM) in lowlanders (circles, continuous line) and Sherpa (inverted triangles, dashed line). All variables were calculated over 15 s time windows at 9 points: just before the start and in the middle of the first, second and third bout of stimuli, and just before the trains delivered at R1, R2 and R3. All values are expressed as percentage of baseline, which is represented by variables calculated just before the beginning of the first bout. For all measures, data were pooled for the two groups because the two-way repeated measures ANOVAs reported only main effects of time. Open symbols represent data points significantly different from baseline. A, muscle tissue oxygenation index (TOI) was significantly decreased at all time points during the fatiguing protocol except the start of the third bout (P < 0.05), and greater than baseline throughout recovery (P < 0.05). B, total haemoglobin (tHb) was increased at all time points during both fatigue and recovery (P < 0.05). C, oxygenated haemoglobin (O 2 Hb) showed a decrease during the first bout (P < 0.05), whereas at the start of the second and third bout as well as during recovery it was increased compared to baseline (P < 0.05). D, deoxygenated haemoglobin (HHb) showed a significant increase throughout the fatiguing protocol (P < 0.05), whereas it was decreased from baseline at any time point during recovery (P < 0.05). J Physiol 596.22 groups. Overall, both eDO 2 and mNIRS-related variables suggest a similar balance of convective oxygen delivery and diffusion capacity between groups.
Peripheral fatigue-related measures. Differences in force output between lowlanders and Sherpa were found early in the fatiguing protocol and during recovery. Importantly, as noted above, these differences between groups are likely not to be ascribed to dissimilar convective oxygen delivery or diffusion capacity. Instead, it would seem that the muscular metabolic adaptations for Sherpa (Allen et al. 1997; Hochachka et al. 2002; Horscroft et al. 2017; Murray et al. 2018) confer contractile advantages at high altitude.
At the end of the first bout, the decline of peak force of the electrically-evoked tetani was more marked in lowlanders than in Sherpa. At the start of the bout, Sherpa displayed a potentiation of peak force that was absent in lowlanders. It is uncertain why potentiation would not occur in lowlanders but, with repeated activation, muscle force output results from a competing balance between potentiation and fatigue (Rassier & MacIntosh, 2000) . Compared to lowlanders, Sherpa at altitude have greater energetic reserve (resting concentrations of ATP and PCr), coupling between ATP demand and supply, mitochondrial efficiency, and protection against oxidative stress (Allen et al. 1997; Hochachka et al. 2002; Horscroft et al. 2017; Murray et al. 2018) . As an aside, the greater ATP supply-demand coupling compared to lowlanders is also evident in skeletal muscles of Quechua Andeans (Matheson et al. 1991) . Quechua and Sherpa populations display numerous similar adaptations to hypoxia but, given that they last shared ancestors ß30,000 years ago, they also possess different physiological characteristics (Hochachka et al. 1998) . This extended period of separate Open symbols represent data points significantly greater than baseline. For all measures, data were pooled for the two groups because the two-way repeated measures ANOVAs resulted in main effects of time only. All variables were significantly greater than baseline throughout the fatiguing and recovery periods (P < 0.05).
evolution coupled with the disparity in length of time living at altitude (>21,000 years for Sherpa ancestors (Zhao et al. 2009 ) vs. ß11,000 years for Andeans (Aldenderfer, 2003) ) means that one should not automatically equate the physiology of the two populations. Nevertheless, data obtained from Sherpa (Allen et al. 1997; Hochachka et al. 2002; Horscroft et al. 2017; Murray et al. 2018) suggest that, in our study, the muscles of Sherpa compared to lowlanders likely had lower accumulation of inorganic phosphate and reactive oxidative species during the fatiguing protocol, and faster metabolite clearance in recovery. Inorganic phosphate is the most potent metabolite involved in skeletal muscle fatigue (Westerblad et al. 2002; Allen et al. 2008 ) so any reduction in concentration would be beneficial. In terms of oxidative stress, although the mechanisms are still poorly understood, there is clear evidence that endurance is impaired by reactive oxygen species during submaximal fatiguing contractions (Allen et al. 2008; Cheng et al. 2016) . Thus, lower production of reactive oxidative species may promote lower peripheral fatigability. These muscle metabolic characteristics of Sherpa may have enabled potentiation and a slower decay of force during the first bout, and faster recovery of pRFD, CI 200 and HRT.
Of note, the behaviour of pRFD and CI 200 within and between groups after the fatiguing protocol paralleled each other, indicating that restoring pRFD is a determinant for the recovery of CI 200 , the latter variable being of most practical importance (among those analysed) for performance. The magnitude of the impulse over a certain period of time (in this case over the first 200 ms of the contraction) is directly proportional to the angular velocity of the knee joint, had the leg been allowed to move (Aagaard et al. 2002) . Hence, recovery of CI 200 favours recovery of the capacity to produce mechanical work and, in turn, to displace the centre of mass in whole-body movements (Chapman, 2008) . The faster recovery of CI 200 in Sherpa compared to lowlanders may therefore confer an advantage during physical exertion at high altitude.
Conclusions
Our research showed that with muscle fatigue induced by intermittent electrically-evoked contractions, the force-generating capacity of the quadriceps of Sherpa was less impaired in the first part of the protocol and recovered faster after the fatiguing task. These differences in muscle capacity at high altitude seemed to occur independently of bulk muscle oxygen delivery. The greater resistance to fatigue in Sherpa people is presumably the result of muscular adaptations after millennia of life at high altitude (Horscroft et al. 2017; Murray et al. 2018) . Functionally, the intrinsic resistance to muscle fatigue and faster recovery favours repeated force production at high altitude.
